Haemonetics (HAE) Tops Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $120.22 +0.48%
Revenue Growth %: +5.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
LTBR, AES, SYRS, More
Revenue Growth %: +5.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $1.31, $0.06 better than the analyst estimate of $1.25. Revenue for the quarter came in at $338.97 million versus the consensus estimate of $331.91 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loews Corp. (L) Reports Q3 EPS of $1.50
- Check Point Software Technology (CHKP) call put ratio 1.2 calls to 1 put with a focus on November puts as share price down 6.2%
- Interactive Brokers reports October 2026 brokerage metrics
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
